We apologize if your country is not currently listed. Please feel free to contact us through our global page and we will do our best to assist you.
Böblingen, 23. September 2026 - When Heike Drechsler spoke at Wörwag Pharma in Böblingen, medals and records were not the focus. Instead, she shared…
Böblingen, September 2026 – The baseline results of the PREDIP study have been published, providing valuable real-world insights into the diagnosis,…
Böblingen, July 15, 2026 – Wörwag Pharma announces a change in leadership at its Romanian subsidiary.
Böblingen / Dübendorf (Switzerland), May 2026 – Wörwag Pharma and Biomed AG have entered into a collaboration for the Swiss market, effective 1 April…
Böblingen / Łódź (Poland), May 2026 – Five years ago, Wörwag Pharma took an important strategic step by integrating its own manufacturing operations.…
Böblingen, May 2026 – Up-to-date, practical, and international science: With the Health Academy, Wörwag Pharma is launching a new global webinar…
Böblingen, February 5, 2026 – Wörwag Pharma achieved a significant increase in revenue in 2025, reaffirming its growth trajectory in a challenging…
Böblingen, May 28, 2025 – Wörwag Pharma has expanded its product range with the innovative dietary fiber supplement ReDia®.
Böblingen, February 20, 2025 – The family-owned company Wörwag Pharma achieved an organic revenue growth of 10.5% in 2024, significantly outperforming…
The activity of acute respiratory diseases is at a high level this cold season (1). Accordingly, the risk of infection is high. Often underestimated:…